TMC PULSE

March 2017

Issue link: https://tmcpulse.uberflip.com/i/792366

Contents of this Issue

Navigation

Page 6 of 39

t m c » p u l s e | m a r c h 2 0 1 7 5 We want to close our seed round in the next cou- ple of months, do a clinical test in the next six months and submit to the FDA in the next year. — JESSICA TRAVER Co-founder and chief executive officer of IntuiTap Medical quickly—especially if the patient lands in the emergency room. The startup's journey began in August 2015, when Traver found herself grouped with Nicole Moskowitz, Xavier Garcia- Rojas, M.D., Ph.D., and Yashar Ganjeh, Ph.D., as part of the inaugural TMC Biodesign program—a paid, one-year fellowship that brings together innovators to build new digital health and device solutions. The team members came from various backgrounds: Traver and Ganjeh from mechanical engineering, Moskowitz from biomedical engineering, and Garcia-Rojas from radiology. They rotated through different TMC hospitals, watching surgeries and try- ing to understand the needs of patients and health care professionals. After visiting emergency rooms and speak- ing with physicians who perform spinal taps and epidurals, the team decided to create a device that provides a real-time image of the spine's vertebrae. One year later, they had demon- strated that their need was viable, conducted studies, raised part of a seed round and created the company. Traver became CEO; Moskowitz became chief technology officer; Xavier Garcia-Rojas became chief medical officer; and Yashar Ganjeh, the executive vice president. After graduating from the Biodesign program, the IntuiTap Medical team was accepted into the four-month medical device cohort at the TMCx accelerator, a program within the TMC Innovation Institute. That wrapped last November. Moskowitz, 26, and Ganjeh have spent the past few months in Chicago, working with Insight Product Development to redesign the IntuiTap prototype with an eye toward ergonom- ics and adaptability in the operating room. They're also working on the tac- tile sensor, the part of the device that measures information from its interaction with an environment— in this case, a person's spinal column. The goal: a higher resolution image and greater accuracy. When the new proto- type is complete, IntuiTap will begin bench-testing and start its institutional review board (IRB) study with both imaging and needle insertion. The IRB is a group formally designated to review and monitor biomedical research involving human subjects. Getting to this stage was a pro- tracted lesson in patience and perse- verance. But in recent months, IntuiTap has gained national attention. The device won a Johnson & Johnson Innovation award and the 2016 HealthTECH Startup Competition. Traver also participated as a finalist in SoGal Ventures' SoGal Summit, which supports female entrepreneurs. In addition, Traver and Moskowitz made the Forbes 30 Under 30 list for health care. Forbes pored over more than 15,000 applications to build a list of 600 young entrepreneurs in 20 differ- ent industries to honor in 2017. "It has been an incredible jour- ney—throughout and beyond our TMC fellowship and accelerator experi- ences—learning, implementing and liv- ing the biodesign process," Moskowitz said. "And it is truly humbling to be recognized like this along the way. To me, it is not only unexpectedly exciting recognition for our team, but also validation for the important role the TMC Biodesign process—that is, a uniquely comprehensive, needs- based approach—plays in solving health care problems for our and future generations." Happy Match Day. cookiedelivery.com Celebrate Match Day with warm cookies, delivered.

Articles in this issue

view archives of TMC PULSE - March 2017